Free Trial
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI logo
$0.0003 0.00 (0.00%)
As of 07/11/2025

About Motus GI Stock (NASDAQ:MOTS)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.00
$0.08
Volume
42 shs
Average Volume
4,274 shs
Market Capitalization
$1.73 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

MOTS Stock News Headlines

MOTS Motus GI Holdings, Inc. - Seeking Alpha
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

MOTS Stock Analysis - Frequently Asked Questions

Motus GI's stock was trading at $0.0002 on January 1st, 2025. Since then, MOTS shares have increased by 50.0% and is now trading at $0.0003.

Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its quarterly earnings data on Friday, November, 12th. The company reported ($30.00) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($30.00). The business earned $0.14 million during the quarter, compared to analyst estimates of $0.12 million.

Motus GI's stock reverse split before market open on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Motus GI (MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Acasti Pharma (ACST) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MOTS
CIK
1686850
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$319 thousand
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
5,769,000
Free Float
5,749,000
Market Cap
$1.73 thousand
Optionable
Not Optionable
Beta
1.02
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:MOTS) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners